Key Metrics
CiteScore 

19.7
Eigenfactor 

0.01 - 0.05
Impact Factor 

10 - 15
SJR 

Q1Oncology

SNIP 

3.26
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of the National Cancer Institute
Journal of the National Cancer Institute Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | OXFORD UNIV PRESS INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1940 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of the National Cancer Institute ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of the National Cancer Institute
RESPONSE: Re: Melanocytic Nevi, Solar Keratoses, and Divergent Pathways to Cutaneous Melanoma
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
Prostate-specific antigen screening in elderly men.
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
Title not available
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
What's All the Buzz? Fruit Flies Provide Unique Model for Cancer Research.
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
Stat Bite: Lifetime Risk of Being Diagnosed With Cancer
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
For investigational targeted drugs, combination trials pose challenges.
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
RESPONSE: Re: Melanocytic Nevi, Solar Keratoses, and Divergent Pathways to Cutaneous Melanoma
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
Prostate-specific antigen screening in elderly men.
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
Title not available
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
What's All the Buzz? Fruit Flies Provide Unique Model for Cancer Research.
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
Stat Bite: Lifetime Risk of Being Diagnosed With Cancer
- 3 Dec 2003
- CancerSpectrum Knowledge Environment
For investigational targeted drugs, combination trials pose challenges.
- 3 Dec 2003
- CancerSpectrum Knowledge Environment